Literature DB >> 16360045

Management of heart failure after cardiac resynchronization therapy: integrating advanced heart failure treatment with optimal device function.

Juan M Aranda1, Gregory W Woo, Richard S Schofield, Eileen M Handberg, James A Hill, Anne B Curtis, Samuel F Sears, J Sean Goff, Daniel F Pauly, Jamie B Conti.   

Abstract

Cardiac resynchronization therapy (CRT) is an established adjunctive treatment for patients with systolic heart failure (HF) and ventricular dyssynchrony. The majority of recipients respond to CRT with improvements in quality of life, New York Heart Association functional class, 6-min walk test, and ventricular function. Management of HF after CRT may include up-titration of neurohormonal blockade and an exercise prescription through cardiac rehabilitation to further improve and sustain clinical outcomes. Diagnostic data provided by the CRT device may help to facilitate and optimize treatment. Initial nonresponder rates remain problematic. We suggest a simple step-by-step management and troubleshooting strategy that integrates device function with advanced HF therapy in patients who do not initially respond to CRT. This algorithm represents a new, comprehensive, collaborative approach between the HF and electrophysiology specialists to further improve and sustain outcomes in the field of CRT.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16360045     DOI: 10.1016/j.jacc.2005.03.078

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  9 in total

1.  Increasing knowledge and changing views in cardiac resynchronization therapy.

Authors:  Laszlo Buga; John G F Cleland
Journal:  Heart Fail Rev       Date:  2012-11       Impact factor: 4.214

Review 2.  How to improve outcomes: should we put more emphasis on programming and medical care and less on patient selection?

Authors:  Laszlo Buga
Journal:  Heart Fail Rev       Date:  2012-11       Impact factor: 4.214

Review 3.  Biventricular and novel pacing mechanisms in heart failure.

Authors:  Christina Salazar; William T Abraham
Journal:  Curr Heart Fail Rep       Date:  2009-03

Review 4.  Cardiac resynchronization therapy in NYHA class IV heart failure.

Authors:  Michelle Khoo; Patricia A Kelly; JoAnn Lindenfeld
Journal:  Curr Cardiol Rep       Date:  2009-05       Impact factor: 2.931

5.  Cardiac resynchronization therapy: can we make our heart failure patients smarter?

Authors:  Jamie B Conti; Samuel F Sears
Journal:  Trans Am Clin Climatol Assoc       Date:  2007

6.  Assessment of distribution and evolution of mechanical dyssynchrony in a porcine model of myocardial infarction by cardiovascular magnetic resonance.

Authors:  Khaled Z Abd-Elmoniem; Miguel Santaularia Tomas; Tetsuo Sasano; Sahar Soleimanifard; Evert-Jan P Vonken; Amr Youssef; Harsh Agarwal; Veronica L Dimaano; Hugh Calkins; Matthias Stuber; Jerry L Prince; Theodore P Abraham; M Roselle Abraham
Journal:  J Cardiovasc Magn Reson       Date:  2012-01-06       Impact factor: 5.364

7.  Influence of intrinsic myocardial conduction on paced QRS morphology during cardiac resynchronization therapy follow up.

Authors:  Rajendra Deshmukh; K Latchumanadhas; Ajit S Mullasari; Ulhas M Pandurangi
Journal:  Indian Pacing Electrophysiol J       Date:  2008-08-01

8.  Earlier Right Ventricular Pacing in Cardiac Resynchronization Therapy for a Patient with Right Axis Deviation.

Authors:  Yusuke Hattori; Kohei Ishibashi; Takashi Noda; Hideo Okamura; Hideaki Kanzaki; Toshihisa Anzai; Satoshi Yasuda; Kengo Kusano
Journal:  Intern Med       Date:  2017-08-10       Impact factor: 1.271

9.  Outcomes of Cardiac Contractility Modulation: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Authors:  Ramy Mando; Akshay Goel; Fuad Habash; Marwan Saad; Karam Ayoub; Srikanth Vallurupalli; Waddah Maskoun
Journal:  Cardiovasc Ther       Date:  2019-06-17       Impact factor: 3.023

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.